NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Share Price Passes Above 50 Day Moving Average – Should You Sell?
NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.00 and ...
Business Wire1mon
NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
--(BUSINESS WIRE)--NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces the completion of the sale of its Avenova eyecare business and related ...
Healio25d
NovaBay completes sale of Avenova to Physician Recommended Nutriceuticals
NovaBay Pharmaceuticals has completed the sale of its Avenova brand and related assets to Physician Recommended Nutriceuticals for $11.5 million, according to a company press release. As Healio ...
StockNews.com Initiates Coverage on NovaBay Pharmaceuticals (NYSE:NBY)
Research analysts at StockNews.com began coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Get Free Report) in a report issued on Sunday. The firm set a “hold” rating on the stock. Separately, ...